FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study

INTRODUCTION: One‐third of the patients with pancreatic cancer present with locally advanced unresectable pancreatic cancer (LAPC). Our aim was to determine survival outcomes and toxicity after FOLFIRINOX (leucovorin, fluorouracil, irinotecan, and oxaliplatin) followed by radiotherapy (RT) in biopsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Suker, Mustafa, Nuyttens, Joost J., Groot Koerkamp, Bas, Eskens, Ferry A. L. M., van Eijck, Casper H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221154/
https://www.ncbi.nlm.nih.gov/pubmed/30259526
http://dx.doi.org/10.1002/jso.25233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221154/
https://www.ncbi.nlm.nih.gov/pubmed/30259526
http://dx.doi.org/10.1002/jso.25233

Ejemplares similares